T1	Participants 54 94	progressive Multiple Sclerosis (ACTiMuS)
T2	Participants 282 331	patients with progressive multiple sclerosis (MS)
T3	Participants 884 911	single centre (Bristol, UK)
T4	Participants 913 948	Eighty patients with progressive MS
